“We want to expand cancer care in our state, not just in our traditional local market,” Adrienne Kirby told POLITICO New Jersey.
Earlier this month, Cooper, located in Camden, opened a 30-bed inpatient unit to match the patient experience at the flagship outpatient facility which opened in 2013, Kirby said.
Cooper has satellite facilities in Voorhees and Willingboro and is eyeing future expansion at the Jersey Shore as it continues to draw New Jersey patients who otherwise may have gone to nearby Philadelphia-based medical centers, like Penn Medicine’s Abramson Cancer Center, Fox Chase Cancer Center and Jefferson’s Sidney Kimmel Cancer Center.
Cooper saw a 20-percent combined increase in inpatient and outpatient volume for cancer treatment in the first year of the partnership, according to internal numbers, and has seen continued growth of 8 percent to 9 percent since, Winn said.
The MD Anderson-Cooper partnership is part of a growing nationwide trend as the world’s top cancer centers seek to form strategic alliances across state lines.
There has also been an increased push from the federal level regarding cancer research collaborations, since Vice President Joe Biden began outlining his cancer “moon shot” initiative earlier this year in the wake of his son’s death from brain cancer.
For Jennings’ full story, click here.
Follow Katie Jennings on Twitter @katiedjennings.